Insurance Companies in Virginia and Pneumonia

Insurance companies in Virginia, represented by USA-Online-Health-Insurance.com, subsidize the medical care for thousands of patients every year who contract pneumonia. Pneumonia is a lung infection in which the alveoli of the lungs become full of fluid. The alveoli are tiny sacs that are supposed to absorb oxygen.

About 3 million people in the U.S. get pneumonia every year. Approximately 17% of these people end up in the hospital, and 5% will die of pneumonia. Bacteria and viruses are the most common causes of pneumonia. However, fungi and parasites can also cause pneumonia. Inhalants can also cause it, infecting the alveoli.

When the alveoli are attacked, whether by bacteria, virus, fungi, or aspiration, the immune system sends white blood cells to attack the foreign body. Living organisms, such as bacteria and viruses, begin multiplying in the alveoli. This, in combination with the white blood cells, causes the alveoli to fill with pus and other fluids.

For bacterial forms of pneumonia, antibiotics are the first line of defense. However, one of the side effects of severe pneumonia and antibiotic treatment is that as the pneumococcus bacteria die, they release toxins that can be as lethal as the pneumonia itself. Insurance companies in Virginia are well aware of this complication, as they strive to provide medical care for their customers.

Dr. Rudolf Lucas, a vascular biologist from the Medical College of Georgia, says that you have to take the antibiotics to kill the pneumonia, or the illness will kill you any way. However, researchers may have found a hormone that will stop the toxins from being released and causing a "second wave" of illness.

Your policy with insurance companies in Virginia will cover medical diagnosis and treatment of pneumonia. You get the disease when you inhale the bacterium, which settles in your lungs and begins to reproduce, causing a buildup of mucus, with a cough and fever following, along with the inability to take a good breath. At this point, antibiotics are in order. However, when the pneumococcus dies, it releases pneumolysin which can form holes in the alveoli. Once the pneumolysin makes these holes, it escapes to attack the capillaries nearby. This infiltration causes fluid to; once again, build up in the lungs, making the patient as sick as they were before. In addition, the pneumolysin keeps the body from removing the fluid from the lungs through natural systems.

In the research literature made available to insurance companies in Virginia, the scientists first noticed a growth hormone-releasing hormone in the alveoli in cases of pneumonia. This hormone was usually present in the heart muscle as it tries to recover from a heart attack. In studies and experiments, the researchers discovered that this hormone sequence would actually stop the leakage in the air sacs of the lungs if they have been compromised by pneumolysin.

Your insurance companies in Virginia will continue to follow development of this therapy, as its approval by the FDA will make a tremendous difference in survival rates of the 5%.